Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) EBITDA (2011 - 2026)

Analysis

Cerenome (CNSY) EBITDA (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn 493.00 Mn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn - -505.13 Mn
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 133.12 Mn
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -1.55 Mn
10 Cerenome 20.42 Mn 11.83 Mn - -9.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.06 Mn
Mar 31, 2026 -7.12 Mn
Dec 31, 2025 -5.74 Mn
Sep 30, 2025 -4.48 Mn
Jun 30, 2025 -1.54 Mn
Mar 31, 2025 -3.54 Mn
Dec 31, 2024 -3.90 Mn
Sep 30, 2024 -3.80 Mn
Jun 30, 2024 -3.70 Mn
Mar 31, 2024 -3.30 Mn
Dec 31, 2023 -3.86 Mn
Sep 30, 2023 -3.25 Mn
Jun 30, 2023 -1.49 Mn
Mar 31, 2023 -4.72 Mn
Dec 31, 2022 -5.57 Mn
Sep 30, 2022 -5.09 Mn
Jun 30, 2022 -5.12 Mn
Mar 31, 2022 -3.93 Mn
Dec 31, 2021 -3.94 Mn
Sep 30, 2021 -3.50 Mn